Loss of heterozygosity of the mannose 6-phosphate/insulin-like growth factor II receptor and p53 genes in human hepatocellular carcinoma

Hepatology Research

Volumn 20, Issue 1, 2001, Pages 68-83

  Kishimoto, Yosuke ^a   Morisawa, Tsuyoshi ^a   Kitano, Masayuki ^a   Shiota, Goshi ^a   Horie, Yasushi ^b   Suou, Takeaki ^a   Ito, Hisao ^a   Kawasaki, Hironaka ^a   Hasegawa, Junichi ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY HOSPITAL   (Japan)

Author keywords

Hepatocellular carcinoma; Liver cirrhosis; Loss of heterozygosity

Indexed keywords

DNA; MANNOSE 6 PHOSPHATE; PROTEIN P53; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISSECTION; FEMALE; GENE LOCUS; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0035072094     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(00)00130-3     Document Type: Article

References (38)

1. Primary liver cancer in Japan
2. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
3. Loss of the tumor suppressor p53 gene at the liver cirrhosis stage in Japanese patients with hepatocellular carcinoma
4. Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor
5. Insulinlike growth factor-II/mannose 6-phosphate receptor is expressed on CC14-exposed rat fat-storing cells and facilitates activation of latent transforming growth factor-beta in cocultures with sinusoidal endothelial cells
6. Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors
7. Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis
8. K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas
9. Allele-specific loss in chromosome 9p in preneoplastic lesions accompanying non-small-cell lung cancers
10. Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism
11. An Alu polymorphism intragenic to the TP53 gene
12. Dinucleotide repeat polymorphism at the IGF2R locus
13. Improving the polymorphism content of the 3′ UTR of the human IGF2R gene
14. Ancient DNA: Extraction, characterization, molecular cloning, and enzymatic amplification
15. Polymerase chain reaction-based non-RI approaches for detection of allelic loss in thp53 tumor suppressor gene in hepatocellular carcinoma for clinical use
16. Subregional mapping of 8 single copy loci to chromosome 6 by fluorescence in situ hybridization
17. Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors
18. M6P/IGF2R receptor: A candidate breast tumor suppressor gene
19. Deletion of the M6P/IGF2R gene in primary hepatocellular carcinoma
20. Failure to detect genetic alteration of the mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) gene in hepatocellular cercinomas in Japan
21. Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma
22. Accumulation of allele loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma
23. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma
24. Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile
25. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens
26. Clonal growth of hepatitis B virus-integrated hepatocytes in cirrhotic liver nodules
27. Clonal analysis of regenerative nodules in hepatitis C virus-induced liver cirrhosis
28. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3
29. Contiguous patches of normal human mammary epithelium derived from a single stem cell: Implications for breast carcinogenesis
30. Loss of heterozygosity in normal tissue adjacent to breast carcinomas
31. Multiple head and neck tumors: Evidence for a common clonal origin
32. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas
33. p53 gene mutation spectrum in hepatocellular carcinoma
34. Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation
35. The clinical significance of p53 gene mutation in hepatocellular carcinomas from Japan
36. Immunohistochernical analysis of p53 protein overexpression in liver cell dysplasia and in hepatocellular carcinoma
37. P53 expression in patients with and without hepatocellular carcinoma
38. Immunohistochernical detection of aberrant p53 expression in hepatocellular carcinoma